AngioDynamics (ANGO) vs Azenta (AZTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azenta (AZTA) has outperformed AngioDynamics (ANGO) over the past year, gaining 11.7% versus a gain of 1.0%. Over five years, ANGO leads with a -59.0% price change compared with -65.2% for AZTA. Azenta is the larger company by market cap ($1.58 billion vs $472.3 million), about 3.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | AZTA |
|---|---|---|
| Share price | $11.23 | $36.00 |
| Market cap | $472.27M | $1.58B |
| 1-day change | -20.86% | +0.31% |
| YTD return | -12.54% | +8.24% |
| 1-year return | +0.99% | +11.70% |
| 5-year return | -58.97% | -65.20% |
| Forward P/E | — | 65.16 |
| EPS (TTM) | $-0.88 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $593.82M |
| Revenue growth (YoY) | — | +3.55% |
| Net income (latest FY) | — | $-55.76M |
| Gross margin | — | 45.52% |
| Operating margin | — | -4.52% |
| Net margin | — | -9.39% |
| 52-week high | $16.29 | $46.41 |
| 52-week low | $9.39 | $15.93 |
| Distance from 52-week high | -31.06% | -22.43% |
| Analyst consensus | none | buy |
| Avg. price target upside | +78.09% | +2.78% |
| Average volume | 557.83K | 875.72K |
| Shares outstanding | 42.05M | 43.81M |
| Employees | 632 | 2,900 |
| Sector | Healthcare | Technology |
| Industry | Medical Instruments & Supplies | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Azenta is about 3.3 times larger than AngioDynamics by market value ($1.58B vs $472.27M).
- AZTA has outperformed ANGO by 10.7 percentage points over the past year.
- The two companies sit in different sectors: AngioDynamics in Healthcare and Azenta in Technology.
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Technology · Industrial Machinery/Components · 2,900 employees
ANGO vs AZTA FAQ
Which is bigger, AngioDynamics or Azenta?
Azenta (AZTA) is larger, with a market capitalization of $1.58B compared with $472.27M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or AZTA?
AZTA returned +11.70% over the past 12 months, compared with +0.99% for ANGO (price return, excluding dividends). Past performance does not predict future results.
Are AngioDynamics and Azenta in the same industry?
No. AngioDynamics is in the Healthcare sector, while Azenta is in Technology.